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DISCUSSION
Dr R. James Valentine, (Dallas, Tex). I congratulate the
authors on an interesting and provocative study. Endoleaks and
other problems are expected in a minority of patients who have had
endovascular aneurysm repair (EVAR). Most of us have assumed
that patients will be compliant with follow-up as a condition of
placing these devices. In this retrospective study, however, the
authors found that a third of their EVAR patients did not comply
with an established follow-up routine. The authors’ most impor-
tant finding is that there were significantly more major adverse
events in the patients with inadequate follow-up compared to
those with complete follow-up. This clearly demonstrates that the
long-term success of EVAR is dependent on compliance with a
monitoring program. As the authors suggest, these findings might
be representative of a real problem on a national level.
One might object to the notion that the Greenville Hospital
System represents the general practice of vascular surgery in the
US. However, it is difficult to argue with the authors’ conclusion
that long-term follow-up for EVAR is considerably worse outside
of controlled clinical trials. The addition of a full-time clinical
research nurse did not improve the follow-up, so we are left
wondering whether the findings are a function of the patients in
Greenville, South Carolina. This brings me to me first question.
Where did the patients come from? Did distance from home to the
hospital have an impact on follow-up compliance?
The data from the present study are remarkably similar to our
findings in a VA study evaluating compliance with a watchful
waiting program for small aneurysms.1We found that about a third
of the patients did not return for repeat imaging studies, similar to
the proportion of your patients who were lost to follow-up after
EVAR.My second question is whether we might be able to predict
poor compliance based on behavior before EVAR. Was there any
indication that your patients missed appointments to follow aneu-
rysms when they were smaller?
The findings in this study should send a message of caution:
EVAR is clearly not appropriate for all patients. My final question
is how are you going to integrate this information into your
practice? Will you try to predict compliance as a condition of
placing EVAR, and do you have any suggestions on how we can
improve the compliance rate in general practice?
DrWesley B. Jones:With respect to the first question of where
the patients come from in our patient population, the majority of our
patients come within a 20-mile radius from our institution, at least
80%. It didn’t appear that distance or geographic locationwas a factor
in poor follow-up compliance.
With respect to the second question about patients with poor
follow-up compliance in abdominal aortic aneurysms and if there is
anything we could do to predict this poor compliance. Clearly, that
was felt to be the next step from our study, and we didn’t arrange the
study for logistic regression to identify any associated patient variables
that may be associated with poor follow-up compliance. This may
bear a second study from us on this point. The crux of the problem
was asymptomatic patients don’t appear to feel like they need to go to
the doctor and this has been shown time and time again previously.
With respect to the third question of what do we do next and
how are we are going to integrate in our practice. We have
discussed this and we feel that there are two ways to do this. One
may be to take a page from bariatric surgery programs and preop-
eratively screen these patients aggressively for patients that would
be well compliant, and those that we can identify preoperatively as
being poorly compliant we would offer traditional open repair. The
other opportunity would be a postoperative environment that
would foster good follow-up compliance. One might even argue
that financial incentives to the patient, such as breaks in their
insurance costs or some kind of fiscal reward for actively participat-
ing in preventative care, may be an opportunity for improvement.
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INVITED COMMENTARY
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In the abdominal aortic aneurysm (AAA) endovascular
repair (EVAR) post-procedural management paradigm, optimal
graft surveillance methods and intervals for individual patients
remain poorly defined. Many post-EVAR AAA patients undergo
what in retrospect prove to be unnecessary, expensive, and
potentially morbid imaging studies, whereas others experience
sometimes catastrophic device-related events between pre-
scribed imaging intervals.
JOURNAL OF VASCULAR SURGERY
September 2007440 Jones et al
Although axiomatic in modern medical practice, the premise
of this article—patients rigorously followed up will achieve better
procedural outcome—is not fully justified by the data presented.
The authors were not able to prove the primary study hypothesis,
defined in the abstract, that late follow-up rates for EVAR in
general practice are inferior to those reported in protocol-driven
clinical trials, and no significant differences were noted in event
rates for protocol or nonprotocol patients, despite the fact that
protocol patients had longer mean follow-up.
The discussion highlights the potential importance of study
nurse involvement in postoperative patient compliance, but no
differences were noted between protocol and nonprotocol patients
for adherence to their respective recommended follow-up. Patients
in the “incomplete” category experienced more major late compli-
cations, but the numbers were small (n 6 vs n 1), and there is
no direct evidence that “complete” compliance would have pre-
vented these five additional events.
Although the authors’ experiences highlight several real world
concerns related to postprocedural EVAR management, optimal
outcome will likely depend on how rather than how often patients
are followed up. The facts remain that:
1. the ideal surveillance interval for individual patients remains
entirely arbitrary and almost certainly is dependent on device
and patient specific issues,
2. the cost and risks associated with follow-up imaging based on
computed tomography add significantly to the limitations of
EVAR management as currently practiced, and
3. although the performance of EVAR does imply life long vigi-
lance regarding AAA disease status, optimal care will ultimately
derive from patient’s specific data (such as wall or sac tension) or
as of yet to be identified biomarker(s) that may, in a cost-
effective and ideally continuous fashion, directly reflect under-
lying disease status.
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